In Iceland, the healthcare system uses a co-payment system which reduces the expenses for people who frequently need to access healthcare, medications and/or medical devices, such as people living with diabetes (PwD). The threshold for the first and highest level of the co-payment system for medicines and healthcare services is set annually and can vary based on policy updates and budgetary considerations.

All types of insulin and other diabetes and CVD medicines as well as devices and technologies for blood glucose monitoring and insulin administration are available for PwD according to national guidelines.

There is currently no national diabetes plan nor register for PwD. Screening for the prevention of diabetes-related complications is available. However, there is no structured programme to invite PwD to undergo regular screening and they usually have to request it themselves.

This country profile was developed with the help of the Icelandic Diabetes Association (Diabetes Ísland).